Fri, Apr 26, 2024
Whatsapp

8 coronavirus vaccines are undergoing clinical trial: WHO

Written by  Rajan Nath -- May 17th 2020 02:57 PM -- Updated: May 17th 2020 02:59 PM
8 coronavirus vaccines are undergoing clinical trial: WHO

8 coronavirus vaccines are undergoing clinical trial: WHO

A total of 8 coronavirus vaccines are in the clinical trial while another 110 are at various stages of development across the globe, as per the World Health Organisation (WHO) data. While the government is working across the world to curb the spread of coronavirus, the pharmaceutical companies and health institutes in countries like United States, China, and Germany are leading the development to combat the novel coronavirus, the South China Morning Post reported. Currently, several countries like the US, and China have even announced the tentative dates by when they plan to get a COVID-19 vaccine ready. On Saturday, the Chinese health official, Zhang Wenhong stated that a successful vaccine against the novel coronavirus can be administered to humans as early as March in 2021. Zhang was quoted by the Global Times as saying, "There are uncertainties in developing vaccines. Coronaviruses, including MERS and SARS, have not seen a particularly reliable one so far... the best scenario is that if one of the vaccines that people are making is effective and progressing relatively fast, it should be available as soon as possible from March to June next year." Likewise, US President Donald Trump had recently expressed confidence that a COVID-19 vaccine could be available by the end of the year. Also Read | Coronavirus positive cases in India rise to 90,927; death toll 2,872 "I think we'll have a vaccine by the end of the year," said Donald Trump at a Fox News virtual town hall. "We'll have a vaccine much sooner rather than later," he added. COVID-19 continues to affect the world with over 4.6 million people affected with the pandemic while more than 311,425 people have died due to the novel virus. -PTC News


Top News view more...

Latest News view more...